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The changing global malaria epidemiology requires policy makers both in endemic and in  non-
endemic  countries to  regularly reconsider their  malaria prevention  strategies.   In such countries, 
policy adjustments are more limited as the malaria infection is a remote event and  there are limited 
interventions including   prophylaxis,  emergency treatment,  bite avoidance and  changing  
travellers’ behaviour  as interventions. 
 Davlantes and colleagues argue  in  their editorial that the methods that have been  adopted by 
policy makers in the UK(1)  and across Europe(2, 3)for defining travellers’ malaria risk to adjust these 
interventions could be dangerous and erroneous(4).  
 Their starting premise is that these methods will underestimate the malaria risk for travellers. A 
view which does not  fit with the WHO global malaria assessment which describes a  significant 
global decline in malaria since 2000.  The risk of acquiring malaria declined globally by an estimated 
37%. Regionally, the largest decline has  been in S E Asia, the Americas and Western Pacific Region, 
in  the order of -78% and -46% and -65%(5).  These regions mirror the areas where major policy 
changes for malaria recommendations have been recently made (1, 2).  
With decreasing exposure to infectious bites, the accuracy of the risk estimate becomes more 
imprecise, as most travellers to a certain destination will not be exposed. On the other hand, fewer 
travellers will benefit from chemoprophylaxis. A change in strategy relying on disease avoidance 
through increasing dependence on bite avoidance measures for all vector borne diseases in low 
transmission environments, becomes more rational.    However, these messages may be difficult to 
convey to travellers as the lower risk for  malaria may suggest that this infection may no longer be a 
priority. 
 
Dalvantes et al. highlight what all policy makers, recognise: that there are no precise or perfect data 
on which to make decisions.  The editorial describes a need for a holistic approach in the decision 
making process, but  does not include the most critical factor in this process, the tolerability and 
safety(6) of and compliance to chemoprophylaxis by travellers.  For UK and European policy makers 
malaria epidemiology is only part of an equation which also includes efficacy, tolerability, safety of 
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chemoprophylaxis; and access to diagnosis, health care and treatment, and numbers needed to 
prophylaxis to prevent one infection with Plasmodium falciparum.  
Their main argument is around the validity of estimating the travellers’ malaria risk based on 
imported malaria cases and numbers of travellers exposed to infectious mosquito bites in a certain 
region.  While many of their points are both true and recognised by policy groups as weaknesses in 
their methodology,  their main premise is that rates and risk must be  derived from the at-risk 
endemic population. 
We note the authors do not detail the limitations of their methodology, so readers cannot form a 
balanced view.  However, from the limited information on the methodology available to readers on 
their risk assessment, it would appear to be based predominantly on the  regional risk of malaria in 
the local population based on national and WHO reporting.  We would use their argument that the 
local population, with different accommodations, exposure duration and immunity, cannot be 
considered the same at-risk population as transient travellers who differ significantly through life-
style, behaviour and accommodation to local population.   The authors appear to be confident of the 
precision and quality of endemic surveillance data for informing their prophylaxis policy and suggest 
these are validated by CDC.  It would be of value for the readers to understand their audit and QC of 
endemic malaria surveillance and risk calculation.  
European malaria rate estimates are based on  number of cases surveilled in returning travellers and 
in  part,  where there are limited  reports, on local endemicity data. Dalvantes and colleagues   
suggest that this method will contribute to underestimating cases occurring during travel which will 
be  missed in national surveillances.  This is undoubtedly true but, looking at the mounting research 
evidence on malaria presenting during travel to the low transmission countries , very few cases or 
deaths from malaria have been reported during travel (7). In our view, these events do not 
significantly contribute to underestimating risk.  
A combined assessment using numbers of travellers’ malaria cases and local endemicity data is 
favoured by some policy groups as an option to provide evidence of risk. The local rates reflect the 
endemicity of the parasite and the relevance of the endemicity to travellers will depend on other 
additional factors including case reports in returned travellers from the region ideally, or country.  
This data should be represented by more than one country.  These traveller malaria rate may help 
interpret the relevance of the local data. This method of defining risk has been used for many years 
in a number of European countries, with a number of polices  reducing  recommendations for 
chemoprophylaxis for low risk areas.  This change has not resulted in in an increase in traveller’s 
malaria in countries like Switzerland and Germany. 
 The introduction of local data to risk analysis creates a number of complexities. When should local 
data supplant or displace traveller’s data?  Is local data reflective of travellers’ itinerary, accounting 
for exposure, geography  and currency of the data.  Most critically, local data application to the risk 
assessment requires a subjective decision by policy makers, and hereby leads to the historical 
problem of  variable and inconsistent risk interpretation. This remains one of the major 
inconsistencies in generating a standardised method for creating an objective risk assessment.  
Policy makers also differ in their cultural and legal ideologies as well as  risk-taking thresholds.  Some 
policy makers are conservative in their recommendations (no risk of any  infection) and others more 
“liberal” accepting that some risk of infection  while  avoiding adverse events with their 
recommendations.  These cultural differences we believe are important and cannot be measured 
scientifically.  
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As the travellers’ malaria risk estimates are not based on perfect data, we recognise many of the 
weaknesses Davlantes highlights.  Policy makers should be careful not to use single country data, by 
using two or more nations surveillance data sets, risks may be averaged out.  They should not rely 
solely on an absolute rate but use trends in risks (rates) using the same sourced data. Where the 
trend is clear,  adjusting policy to ensure safety of all travellers including those who may be injured 
by chemoprophylaxis, as well as those at risk of malaria.  Tracking the travellers itineraries could 
provide data to geographical exposure in countries with patchy endemicity and provide evidence to 
define high risk destinations (8). We are conscious with the very low rates now identified in S E Asia 
and S America, policy makers may be doing more harm when recommending chemoprophylaxis than 
preventing cases of P falciparum malaria. 
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